Sign up for Table of Contents Alerts.

Email this page

Print this page

Extra Views

p38α: A Suppressor of Cell Proliferation and Tumorigenesis

Lijian Hui, Latifa Bakiri, Ewa Stepniak and Erwin F. Wagner

Purchase article for $19

Subscribe to this journal for $129/year

The mitogen-activated protein kinase (MAPK) p38! is involved in numerous biological processes and is a drug target for inflammation-associated diseases. Genetic analysis in mice demonstrated that fetuses lacking p38! are embryonic lethal owing to impaired placental development. The function of p38! in mice after birth remained unclear until conditional alleles of p38α were used. It was found that p38α is essential for lung function in both neonatal and adult mice. Increased proliferation and impaired differentiation are the hallmarks of p38α-deficient cells. Moreover, mice deficient in p38α are prone to cancer development using carcinogen or oncogene-induced cancer models. p38α can suppress cell proliferation by antagonizing the JNK/c-Jun pathway, which is an important regulator of proliferation and apoptosis. These findings suggest that therapeutic inhibition of p38 might lead to unwanted proliferation. Therefore, a combined inhibition of p38 and other pathways, such as the JNK pathway, should be considered for targeting cancer inflammation.

Authors

Lijian Hui

Research Institute of Molecular Pathology (IMP); Vienna, Austria

Latifa Bakiri

Research Institute of Molecular Pathology (IMP); Vienna, Austria

Ewa Stepniak

Research Institute of Molecular Pathology (IMP); Vienna, Austria

Erwin F. Wagner

Research Institute of Molecular Pathology (IMP); Vienna, Austria

Purchase article for $19

Subscribe to this journal for $129/year